Incyte Corporation (INCY) vs. Revolution Medicines (RVMD): Which Biotech Stock Offers the Better KRAS Opportunity?
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Fri, 28 August 2026
What it is about
Who published it, and when
How it spread - 1 original report
Fri, 28 August 2026
1 report- yahoo.com21:11first to report
Incyte Corporation (NASDAQ:INCY) generated buzz on August 19 when RBC Capital highlighted upcoming ESMO data for its KRAS G12D inhibitor ‘734 in combination with mFOLFIRINOX and GemNabP. RBC noted that while prior data was too limited for firm conclusions, the update should look “very competitive” and support ongoing Phase 3 efforts in first-line pancreatic ductal […]